Latest News for: cabg

Edit

Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme

Nasdaq Globe Newswire 01 Apr 2025
CARLSBAD, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ. QLGN) (the “Company”) announced today they have entered a non-binding Memorandum of Understanding (MOU) to acquire Marizyme (OTC. MRZM) ... .
  • 1
×